CYCC - Cyclacel Pharmaceuticals GAAP EPS of -$0.49 misses by $0.13 revenue of $0.02M
2023-11-14 09:59:20 ET
More on Cyclacel Pharmaceuticals
- Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript
- Cyclacel Pharmaceuticals files for $100M mixed shelf offering - filing
- Seeking Alpha’s Quant Rating on Cyclacel Pharmaceuticals
- Historical earnings data for Cyclacel Pharmaceuticals
- Financial information for Cyclacel Pharmaceuticals
For further details see:
Cyclacel Pharmaceuticals GAAP EPS of -$0.49 misses by $0.13, revenue of $0.02M